Clinical trial · Interventional
Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy
Changhua Christian Hospital
NCT01580358CI-TRIAL-00007230unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Using Shen-Mai-San for cancer patients undergoing chemotherapy or radiotherapy could help these people improve the quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients Undergoing Chemotherapy or Radiotherapy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Shen-Mai San | Drug | — | UNRESOLVED |
| Starch | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Shen-Mai San
- description
- Shen mai san is composed of three herb medicines, Ginseng radis, Liriope spicata, and Schizandrae fructus and was manufactured into concentrated herbal extract and packed with 0.5g per capsule and labeled by Sun-Ten pharmaceutical company in Taiwan with good manufacturing practice (GMP).
- interventionNames
- Drug: Shen-Mai San
- type
- PLACEBO_COMPARATOR
- label
- starch
- description
- Starch in the same granule as intervention group for this double-blind trial
- interventionNames
- Drug: Starch
Primary outcomes (1)
- measure
- Change from baseline in EORTC QOL-C30 at four weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Postoperative patients with histologically confirmed cancer within 3 years and undergoing chemotherapy or radiotherapy * age above 18 years old * signed informed consent * ability to read Chinese, ability for oral intake. Exclusion Criteria: * being pregnancy * on breast feeding * completed chemotherapy or radiotherapy * brain metastasis with Eastern Cooperative Oncology Group (ECOG) performance status of two to four * delusion or hallucination * acute infection * received medications for other clinical trials.
References
Publications (1)
- DERIVEDLo LC, Chen CY, Chen ST, Chen HC, Lee TC, Chang CS. Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial. Trials. 2012 Dec 3;13:232. doi: 10.1186/1745-6215-13-232. PMID 23206440